Address: Damastown Industrial Park Mulhuddart, Dublin.,Ireland
Tel: +353-1-8852700
Web: http://www.rotta.com/en/index.html
Rottapharm established their Irish manufacturing facility in 1999. Construction of the facility commenced in 1998 on a 20 acre site in Mulhuddart, West Dublin. The facility was completed in July 1999 and obtained a manufacturing licence from the Irish Medicines Board in January 2000.
The main product manufactured in Mullhuddart is DONA for which the active ingredient is Glucosamine Sulphate. Both the active ingredient and the finished product in the form of capsules and sachets are manufactured in Mulhuddart. The company also manufactures Bromelain tablets (ANANASE), an anti-inflammatory agent derived from the pineapple tree and a sustained release formulation of Aspirin (TROMALYT).
Employment in the company currently stands at 150 people. The facility has a footprint of 10,000 sq. metres. Product manufactured on site is shipped to over 60 contries.
Mr. Garrahy, can you please begin by introducing yourself and this production facility to our readers? I joined Rottapharm in 1998, when the organization decided to establish its Dublin production…
Mr. O’Leary, when an article in The Guardian last year profiled you and your work, it was titled “Resurrecting the Celtic Tiger.” More recently, Time Magazine put Taoiseach Enda Kenny…
To what extent do you believe Ireland has been successful in building the knowledge economy it set out to create during the 1980’s? I think we have been hugely successful—and…
You noted that, in the ‘old days’, the pharma business had the following characteristics: first of all, it was a molecule-driven business, fueled by blockbuster medicines that met robust medical…
Dr. McLoughlin, you were appointed to your post in April of this year. Can you please give us an impression of what you inherited at this Department when you took…
Dr. Duffy, how has Pfizer’s investment in Ireland evolved over time? Pfizer began operating in Ireland in the late 1960’s, making citric acid which is an ingredient that can be…
Dr. Mitchell, what attracted you to join Novartis after a decades-long career at Astrazeneca? If you had told me a year ago that I would leave the company I’d worked…
Mr. Zimmermann, you came to manage the Irish affiliate of Bayer in 2010, after heading Business Management for Bayer Pharma Headquarters in Berlin. After these two years, what are your…
Prof. Ferguson, when you were recently appointed to direct SFI, local newspapers ran headlines such as “New SFI head to drive economic impact from research investments.” What do you understand…
Mr. Timmons, when we interviewed your colleague at Takeda Products Ireland, Mr. Kieran Leahy, he mentioned that you have a very interesting professional history. Can you begin by telling us…
Mr. Leahy, you worked for Servier for nearly a decade before joining Takeda. What have been the chief differences you have noticed between the smaller, independent, French player, and the…
With an evident recession and cost-cutting measures abound Ms. Nolan elaborates on the new plain on which pharmaceutical players have found themselves upon and how they have adjusted to the…
Novo Nordisk is primarily known as the premier global diabetes player—so let us begin by examining the realities of diabetes in Ireland. In 2012, the International Diabetes Federation estimated that…
See our Cookie Privacy Policy Here
